Skip to main content

Advertisement

Table 1 Demographic data at baseline

From: Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial

Variable C-SLE trained (n= 10) C-SLE non-trained (n= 9) Control (n= 10)
Age, years 12.9 (2.3) 13.0 (1.8) 12.0 (1.8)
Body weight, Kg 48.7 (10.1) 49.7 (12.1) 46.6 (14.5)
Height, m 1.48 (0.09) 1.44 (0.11) 1.51 (0.13)
Body mass index, Kg/m2 22.3 (3.8) 23.9 (3.4) 21.2 (1.7)
Pubertal stages I/II/III/IV/V, number of individuals 1/2/2/2/3 0/2/3/2/2 3/2/1/2/2
SLEDAI-2K, score 5.3 (5.3) 5.6 (6.4) NA
SLICC/ACR-DI, score 0.4 (0.7) 0.4 (0.7) NA
Disease duration, years 3.3 (2.6) 4.3 (2.6) NA
Current dose of prednisone, mg/d 19.8 (17.0) 15.5 (7.7) NA
Cumulative dose of prednisone, g 13.7 (6.7) 20.9 (13.0) NA
Current dose of azathioprine, mg/d 128.6 (39.3) 121.4 (17.2) NA
Cumulative dose of azathioprine, g 58.2 (32.1) 62.2 (41.1) NA
Current dose of chloroquine, g/d 205.8 (51.2) 205.6 (51.2) NA
Cumulative dose of chloroquine, g 129.7 (119.9) 181.3 (121.5) NA
Drugs, number of patients (%)    
Prednisone 10 (100) 9 (100)  
Fluoxetine 1 (10) 0 (0) NA
Diltiazen 1 (10) 0 (0) NA
Enalapril 3 (30) 5 (55) NA
Losartan 1 (10) 1 (11) NA
Anlodipine 0 (0) 2 (22) NA
Carbamazepine 1 (10) 0 (0) NA
Methylphenidate 0 (0) 0 (0) NA
Clopidogrel 0 (0) 0(0) NA
Warfarin 1(10) 0(0) NA
Acetylsalicylic Acid 1 (10) 0 (0) NA
  1. Results are presented as mean (SD) unless stated otherwise. C-SLE, childhood-onset systemic lupus erythematosus; SLEDAI, systemic lupus erythematosus disease activity index; SLICC/ACR-DI, Systemic Lupus International Collaborating Clinics/ACR Damage Index; NA, not applicable.